Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib

    American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899